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Abstract
Background: Propionibacterium acnes was found in lungs and lymph nodes of patients with sarcoidosis and may
induce hypersensitivity type granuloma formation. Data regarding the immune response to P. acnes of European
sarcoid patients are scarce.
Methods: We assessed the total IgG and IgA amount and specific antibodies to P. acnes and to Staphylococcus
aureus, serving as a control, in BAL fluid of 64 patients with sarcoidosis and of 21 healthy volunteers. In a subcohort
of sarcoid patients and controls, TNF-α and GM-CSF production of BAL cells stimulated with heat-killed P. acnes
were measured.
Results: In sarcoid patients, the total IgG and IgA levels in BAL fluid were significantly elevated compared to healthy
volunteers. IgG and IgA titres against P. acnes and S. aureus were increased in sarcoid patients, yet based on the total
amount of antibodies, only antibodies directed against P. acnes were relatively and significantly increased. Furthermore,
BAL cells of sarcoid patients produced significantly more TNF-α and GM-CSF upon stimulation with heat-killed P. acnes
compared to controls.
Conclusions: Patients with sarcoidosis had elevated levels of specific antibodies against P. acnes which suggest contact
with this bacterium in the past. Furthermore, BAL cells of sarcoid patients produced inflammatory cytokines (TNF-α and
GM-CSF) upon stimulation with P. acnes indicating potential involvement of this pathogen in the pathogenesis of
sarcoidosis in some patients.
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Background
Sarcoidosis is a systemic, granulomatous, and non-
infectious disease, which most often affects the lungs.
The key feature of sarcoidosis is a strong interaction of
T-cells and macrophages leading to an exaggerated TH1
immune response, which is thought to be triggered by
antigens in susceptible individuals. The obvious clinical
heterogeneity of sarcoidosis supports the concept that
several different sources of antigens such as bacteria,
foreign particles, autoantigens or other endogenous fac-
tors may be involved. In the past decade, considerable
progress has been made in defining potential antigens
involved in sarcoidosis [1–4]. Especially antigens either
derived from mycobacteria or from propionibacteria
have been associated with sarcoidosis. For both patho-
gens a specific T-cell response was demonstrated in a
high percentage of sarcoid patients [5–9].
Propionibacteria are gram-positive and aero-tolerant
anaerobic bacteria. Particularly Propionibacterium acnes
(P. acnes) is part of the skin, large intestine, mouth and
conjunctiva flora and a common resident of the lung
[10]. Mycobacteria and propionibacteria share many
common features. Most importantly, both are intracellu-
lar pathogens and known for their persistence in macro-
phages due to the extraordinary high lipid content of
their cell walls [11].
In the 80s of the last century P. acnes was identified as
a putative causative agent of sarcoidosis [3]. The group
of Abe and Homma cultivated P. acnes in homogenates
of lymph nodes of patients with sarcoidosis [12]. Since
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then, P. acnes was detected by several, more sophisticated,
methods: Hiramatsu et al. found elevated propionibacter-
ial DNA in bronchoalveolar lavage cells from patients with
sarcoidosis compared to healthy volunteers [13], Ishige
and Ichikawa et al. confirmed and quantified the propioni-
bacterial DNA in BAL cells, lymph nodes and lungs tissue
[10, 14] and Negi et al. detected P. acnes antigens with
monoclonal antibodies in tissue sections [15] of sarcoid
patients. Significantly higher levels of P. acnes genome
were reported in sarcoid patients compared to patients
with tuberculosis or healthy controls [16]. In addition,
antibodies directed against RP35, a fragment of the P.
acnes trigger factor, were found to be elevated in BAL fluid
of sarcoidosis patients [17]. Most of these data are derived
from studies by Japanese groups testing Japanese patients,
while only very limited data exist for Caucasian patients.
Furthermore, P. acnes is able to provoke a granulomatous
TH1 inflammation in mice mimicking sarcoidosis [18–21].
Based on the Japanese data, Y. Eishi formulated the hy-
pothesis that, in sarcoid patients, a latent P. acnes lung
and/or lymph node infection can lead to a hypersensitivity
granuloma formation directed against P. acnes and it’s
derived proteins [3].
In sarcoidosis, elevation of several proinflammatory
cytokines has been shown [22]. Tumour necrosis factor
alpha (TNF-α) and granulocyte macrophage colony-
stimulating factor (GM-CSF) are two key cytokines:
TNF-α is required for granuloma formation, as shown in
several studies in mice [23, 24] and GM-CSF is able to
induce transformation of alveolar macrophages into
multinucleated giant cells [25]. Both, granulomas and
multinucleated giant cells, are the hallmark histopatho-
logical changes in sarcoidosis.
Based on these data we investigated whether specific
P. acnes directed immunoglobulin production could be
detected in Caucasian sarcoid patients, as specific anti-
bodies reflect a previous, in vivo, immune response to
P. acnes. As well, we attempted to prove an immuno-
logic response of BAL cells to P. acnes in vitro.
Methods
Subjects
64 patients with sarcoidosis who underwent bronchoscopy
for routine diagnostic evaluation and 21 healthy volunteers
were included after obtaining their written informed con-
sent. Diagnosis was made by clinical evaluation, HRCT,
laboratory and histologic findings (non-caseating epitheloid
granulomas on tissue biopsies) according to the American
Thoracic Society/European Respiratory Society/World
Association for Sarcoidosis and Other Granulomatous
Disorders (ATS/ERS/WASOG) statement. Bronchos-
copy and bronchoalveolar lavage (BAL) was performed
using standard technique [26]. BAL cells were proc-
essed as previously described [26]. The study was
approved by the local ethics committee of Albert-
Ludwig University Freiburg (231/03).
IgG- and IgA-ELISA
We performed the following ELISA to quantify the total
amount of IgG and IgA: 96 well plates were coated with
1:1000 diluted goat anti-human IgG + IgM+ IgA anti-
bodies (Dianova, Hamburg, Germany). We used 1:300 di-
luted goat anti-human IgG / IgA conjugated with alkaline
phosphatase (Dianova, Hamburg, Germany) as detection
antibodies and p-nitrophenylphosphate (Sigma-Aldrich,
St. Louis, USA) as substrate. The detection limits were
0.8 ng/ml total IgG and total IgA, respectively.
Preparation of P. acnes or S. aureus antigen
Propionibacterium acnes (ATCC 12930) and Staphylococcus
aureus (S. aureus) were cultured, heat-killed and lyophilised
as previously described [27]. The lyophilisate was resus-
pended in carbonate buffer (8.4 g NaHCO3 & 3.56 g
Na2CO3 in 1 l H2O, pH 9.5) by sonification (at 4 °C for
30 min). The bacterial suspension was centrifuged (at room
temperature for 2 min, 20000 g) and concentration of the
supernatant (antigen) was measured using BCA protein
assay (Pierce, Bonn) and adjusted with carbonate buffer to
1 mg/ml. P. acnes and S. aureus antigens were used for
specific ELISA and stimulation of BAL cells.
Anti-P. acnes-IgG/IgA- and Anti-S. aureus-IgG/IgA-ELISA
To measure the relative specific antibodies against P. acnes
and S. aureus the following ELISA was utilized: 1 μg P.
acnes or 0.7 μg S. aureus bacterial antigen was coated on
96-well ELISA maxisorb plates (Nunc, Roskilde, Denmark)
and incubated at 37 °C for one hour followed by 4 °C over-
night. The plates were washed twice with washing buffer
(0.1 % Tween 20 in PBS), then blocked with 200 μl blocking
buffer (2 % BSA in PBS) at room temperature for one hour.
The BAL fluids were diluted with blocking buffer; one
serum was used as standard in each experiment. After
washing, the plates were loaded with standard or samples
in triplicates, incubated at room temperature for two hours
and then washed again. As detection antibodies we used
25 ng alkaline phosphatase linked anti-human IgA or IgA
(Southern Biotechnology, USA) per well. 50 μg pNPP
(Sigma, St. Louis, USA) per well served as substrate. Optical
density (OD) was measured with an ELISA reader (Tecan,
Crailsheim) at 405 nm against a reference value (492 nm).
A non-linear regression standard curve was calculated
(Prism software, GraphPad Inc.) using the ODs of the
standard serum. After adjusting for the dilution factor
relative antibody titres in relative arbitrary units (AU) were
obtained.
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Stimulation of BAL cells with P. acnes and cytokine
measurement
BAL cells were suspended in RPMI medium (Gibco,
Karlsruhe, Germany) supplemented with 10 % fetal calf
serum and 1 % penicillin/streptomycin and put in 24-
well plates (one million BAL cells/ml/well). If indicated,
BAL cells were stimulated with P. acnes lysate (1 μg/ml)
in a 5 % CO2 incubator at 37 °C for 24 h. The super-
natant was harvested, frozen and stored at -80 °C until
cytokine measurement. TNF-α and GM-CSF were quan-
tified in duplicates using DuoSet ELISA Development
System Kits (R&D Systems Europe, UK) according to
the manufacturer’s instructions.
Statistical analysis
Values are expressed as means ± SD. Characteristics of
patients with sarcoidosis and healthy volunteers were
compared using a Mann-Whitney U test for continuous
measures and Fisher’s exact test for categorical mea-
sures. Wilcoxon signed-rank test was used to compare
matched samples. Spearman rank correlation was uti-
lized to establish possible correlations between numer-




The 64 patients had a mean age of 46.1 and a balanced
gender distribution compared to healthy volunteers (see
table 1). The healthy volunteers were significantly younger
(age 28.9, p < 0.0001, table 1). 43 patients had a clinical in-
volvement of hilar lymph nodes (radiologic stage I and II),
21 patients had not (radiologic stage III and IV). Eleven of
the patients had an acute course of the disease, i.e. Löfgren
syndrome. Patients with Löfgren syndrome were not sig-
nificantly younger than sarcoid patients without Löfgren
syndrome (age 40.9 vs. 47.1 years, p = 0.14).
Total IgA/IgG in BAL fluid
The BALF of patients with sarcoidosis is characterized
by a significant increased amount of immunoglobulins
(84.3 μg/ml IgG and 84.9 μg/ml IgA on average) com-
pared to healthy volunteers (12.4 μg/ml IgG and 8.7 μg/
ml IgA, p < 0.0001, Fig. 1). Patients without Löfgren syn-
drome or patients with radiological stage III and IV had
significantly more total IgA in BALF compared with pa-
tients with Löfgren syndrome or with radiological stage I
and II (p = 0.01 and p = 0.04, respectively). There was no
such difference in total IgG in the BALF. There was no
correlation in total IgG or total IgA and age in patients
with sarcoidosis or healthy volunteers, and there was no
significant difference in IgA or IgG levels comparing
male and female sarcoid patients or healthy volunteers,
respectively (all p > 0.05).
Total specific Anti-P. acnes-IgG/IgA- and Anti-S.
aureus-IgG/IgA
The total specific antibodies against P. acnes and against
S. aureus were increased in patients with sarcoidosis (p <
0.0001). There was no difference in total IgG or IgA levels
regarding patients with/without clinical involvement of
hilar lymph nodes (radiological stage I/II compared to
stage III/IV) or with/without Löfgren syndrome.
Specific antibody ratio of P. acnes and S. aureus
To evaluate, if there is a relative increase in specific anti-
bodies, we calculated a ratio between the total specific
anti-P. acnes or anti-S. aureus antibodies (in arbitrary
units) and the total amount of immunoglobulin concen-
trations in the BALF. This ratio was called “specific anti-
body ratio”. The specific antibody ratio of P. acnes-IgGs
were significantly increased in BALF of sarcoid patients
compared to BALF of healthy volunteers (p = 0.0002),
but not the anti-P. acnes-IgAs (p = 0.19). The anti-P.
acnes-IgAs were significantly increased in patients with
Löfgren syndrome (Fig. 2) and in patients with clinical in-
volvement of hilar lymph nodes (radiological stage I/II).
The specific antibody ratio of anti-S. aureus-IgG and –IgA
were not increased in patients with sarcoidosis (p = 0.33
and p = 0.68, respectively).
Cytokine profile of BAL cells after P. acnes stimulation
BAL cells were cultured for 24 h with or without stimula-
tion with heat-killed P. acnes (1 μg/ml). The production of
the proinflammatory cytokines GM-CSF and TNF-α from
untreated and P. acnes-stimulated BAL cells was mea-
sured by ELISA. Strikingly, unstimulated BAL cells of sar-
coid patients had spontaneously elevated levels of TNF-α
(530 ± 505 pg/ml vs. 145 ± 263 pg/ml, p = 0.03, Fig. 3)
compared to BAL cells of healthy volunteers. P. acnes was
neither able to significantly induce GM-CSF nor TNF-α
production in BAL cells of healthy volunteers. Yet, in BAL






n = 21 n = 64
Age [years] 28.9 46.1 p < 0.0001
Sex [male/female] 11/10 34/30 n.s. (p = 1.00)
X-ray type [I/II/III/IV] n. a. 19/24/16/5 n. a.
Löfgren syndrome
[yes/no]
n. a. 11/53 n. a.
Total IgG [μg/ml]
in BALF
12.4 84.3 p < 0.0001
Total IgA [μg/ml]
in BALF
8.7 84.9 p < 0.0001
Definition of abbreviations: BALF bronchoalveolar lavage fluid, X-ray type
according to Scadding [42], IgA/IgG: immunoglobulin A/G, n. a.: not applicable,
n. s.: not significant
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cells from sarcoid patients, P. acnes strongly stimulated
GM-CSF (p = 0.0002) and TNF-α (p = 0.001) production
compared to unstimulated cells (Fig. 3). Thus, in patients
with sarcoidosis, P. acnes stimulated BAL cells produced
1283 ± 932 pg/ml GM-CSF vs. 137 ± 270 pg/ml GM-CSF
in unstimulated cells (p = 0.001).
Discussion
P. acnes is a gram-positive, low virulent bacterium and
is thought to be, beside mycobacteria, a potential factor
involved in the pathogenesis of sarcoidosis. A previous
study reported the presence of P. acnes in BAL cells and
lymph nodes of patients with sarcoidosis [12]. In this
study we investigated the specific immune response to
P. acnes in sarcoid patients.
In accordance with Vandenplas and colleagues, we
showed increased local immunoglobulin production, par-
ticularly higher immunoglobulin G and A concentrations
in the bronchoalveolar lavage of sarcoid patients [28]. The
mechanisms of hypergammaglobulinemia in sarcoidosis
are not fully understood, but three points seem to be clear:
First, IFNg, a hallmark cytokine in sarcoidosis, is a potent
stimulus of IgG secretion by B-cells [29]. Secondly, sev-
eral studies have shown, that the IgG production in sar-
coidosis is compartimentalized i.e. locally produced in
the lung [30, 31]. And thirdly, BAL T-cells from sarcoid
patients stimulate B-cells to secret more immunoglobulins
as well [30]. Furthermore, sarcoidosis is thought to be an
antigen driven hypersensitivity reaction [32]. On the basis
of these data, it was hypothesized that in the lungs in situ
antigen presentation takes place leading to local immuno-
globulin production.
Looking for specific antibodies against P. acnes, we
used S. aureus as control since S. aureus belongs, similar
as P. acnes, to commensals of the skin and the respira-
tory tract [33]. We found elevated total specific anti-
bodies against P. acnes and S. aureus in sarcoid patients.
The increased total amount of IgG and IgA in patients
Fig. 1 Total immunoglobulin levels in BAL fluid. Boxplots of total IgA (a) and total IgG (b) in BAL fluid of patients with sarcoidosis (grey bars) and
healthy volunteers (white bars) (** p < 0.0001)
Fig. 2 Specific antibody ratio of P. acnes and S. aureus. Boxplots of specific antibody ratios of P. acnes in BAL fluid of healthy volunteers (white
bars), Löfgren patients (light grey bars) and non-Löfgren sarcoid patients (dark grey bars). Specific antibody ratios are expressed as ratio between
Anti-P. acnes-IgG [arbitrary units] and total IgG [μg/ml] (a) or as ratio between Anti-P. acnes-IgA and total IgA (b) (**p < 0.005)
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with sarcoidosis (Fig. 1) probably accounts for the en-
hanced total S. aureus titre, since the relative S. aureus
titres were not elevated. This differs completely from the
anti-P. acnes titre which are relatively and absolutely ele-
vated (Fig. 2). Thus, the pulmonary immune system of
sarcoid patients must have encountered P. acnes in the
past. This is the first time an increased specific B-cell
immune response to P. acnes could be proven in Cauca-
sian sarcoid patients.
IgA and IgG prevent, amongst other things, bacteria
and viruses from adhesion to the epithelium. Both, IgG
and IgA are able to reach extravascular spaces; IgG by
passive diffusion and IgA by an active transport across
the epithelium [34]. Anti.-P. acnes-IgA was relatively ele-
vated only in early disease, especially in Löfgren syn-
drome, while anti.-P. acnes-IgG was relatively increased
in chronic disease as well. This finding might indicate
that recent exposure to P. acnes is evident in Löfgren
syndrome. The significance of all studies looking for a
direct confirmation of P. acnes in sarcoid biopsies were
limited to the fact that it is a commensal of the lung and
also present in healthy individuals. Furthermore there is
the possibility of contamination of the samples by P.
acnes, as it is also a major commensal of the upper re-
spiratory tract. With our approach in verifying a previ-
ously occurred exposure with P. acnes in vivo, we were
able to abrogate this experimental limitation. Thus, our
data suggest that Caucasian sarcoid patients had a recent
immunologic response to P. acnes. Our study is limited
by the fact, that our control group is significantly youn-
ger than the sarcoid patients. Aging leads to a decline of
the immune system’s function, a phenomenon called
“immunosenescence”; e.g., the reactivity to antigens is
markedly reduced in older people [35]. We cannot ex-
clude that part of the observed differences is due to
aging, but we assume that the aging influence is mar-
ginal, because there was no correlation in sarcoid
patients or healthy volunteers between total immuno-
globulin levels and age. Because our study is biased re-
garding age, it may be possible that we underestimated
the significance of relative IgG and IgA P. acnes titres
rather than overestimated.
Next we explored, if there is an in vitro response in
BAL cells stimulated with heat-killed P. acnes. Unstimu-
lated BAL cells of patients with sarcoidosis already pro-
duced more TNF-α compared to control BAL cells, as
shown by many groups [36, 37]. The unstimulated GM-
CSF increase was not significant, possibly due to a too
small sample size, and in line with Prior et. al [38].
When stimulated with heat-killed P. acnes, BAL cells of
healthy volunteers were anergic, yet in sarcoid patients,
we saw a highly significant increase in proinflammatory
cytokines such as TNF-α and GM-CSF, which has never
been reported before. This results suggest that stimula-
tion with P. acnes leads to an exaggerated local release
of cytokines necessary for granuloma and multinucleated
giant cell formation, the typical histopathological
changes observed in sarcoidosis [23, 24]. Of interest, in-
creased IL-2 production and BAL T-cell proliferation fol-
lowing stimulation with P. acnes were reported by Mori
and colleagues [39]. However, this phenomenon is not
exclusively for sarcoidosis since also in skin acne an in-
crease of TNF-α after P. acnes stimulation was reported
[40]. Thus, our data indicate that contact of immune
cells to P. acnes may boost the TH1 immune response in
sarcoidosis.
Conclusion
Our findings of P. acnes specific responses in Caucasian
sarcoid patients contribute to improve the understand-
ing of the pathogenesis of sarcoidosis. We show here
that most patients with sarcoidosis have elevated levels
of specific antibodies against P. acnes and have therefore
been in contact with this bacterium in the past.
Fig. 3 Cytokine production after P. acnes stimulation. Boxplots of GM-CSF (a) and TNF-α concentration (b) in supernatant of BAL cells from
patients with sarcoidosis (n = 15, grey bars) and healthy volunteers (n = 10, white bars) that were stimulated with heat-killed P. acnes or left
untreated (*p < 0.05, **p < 0.005)
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Furthermore, BAL cells of sarcoid patients produce in-
flammatory cytokines (TNF-α and GM-CSF) upon stimu-
lation with heat-killed P. acnes suggesting involvement
of this pathogen in the pathogenesis of sarcoidosis. In
accordance with the literature [1, 41] our study supports
the notion that an unknown etiologic event disrupts the
physiological tolerance towards the commensal P. acnes
with subsequent deposition of non-degradable remnants,
which gives rise to a nidus and causes granuloma
formation.
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